• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国原发性高草酸尿症儿科患者的基因型和表型特征

Genotype and Phenotype Characteristics of Chinese Pediatric Patients with Primary Hyperoxaluria.

作者信息

Ge Yucheng, Liu Yukun, Zhan Ruichao, Zhao Zhenqiang, Li Jun, Wang Wenying, Tian Ye

机构信息

Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

出版信息

Hum Mutat. 2023 Sep 14;2023:4875680. doi: 10.1155/2023/4875680. eCollection 2023.

DOI:10.1155/2023/4875680
PMID:40225159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11918535/
Abstract

Primary hyperoxaluria (PH) is a rare monogenic disorder characterized by recurrent kidney stones, nephrocalcinosis, and renal impairment. To study the genotype and phenotype characteristics, we evaluated the clinical data of 42 Chinese pediatric PH patients who were diagnosed from May 2016 to April 2022. We found that patients with the PH3 type showed an earlier age of onset than those with the PH1 and PH2 types (1 versus 5 and 8 years, respectively, < 0.001). Urine citrate was significantly lower in PH1 and PH2 patients than that in PH3 patients (91.81 and 85.56 versus 163.9 g/mg, respectively, = 0.044). Spot urine oxalate levels were slightly higher in PH1 than that in PH2 and PH3 patients (457.9 versus 182.38 and 309.14 g/mg, respectively, = 0.189). A significant negative correlation between the urine calcium/creatinine ratio and the oxalate/creatinine ratio was observed in the entire PH cohort ( = -0.360, = 0.04) and the PH3 cohort ( = -0.674, = 0.003). PH-causative genes showed hotspot mutations or regions, including c.815_816insGA and c.33dup in , 864_865del in , and exon 6 skipping and c.769T>G in . In the PH1 cohort, the estimated glomerular filtration rate (eGFR) was lowest in patients with heterozygous c.33dup. In the PH3 cohort, patients with heterozygous exon 6 skipping presented the lowest eGFR and a significant decrease in the renal survival advantage. In summary, PH1 patients exhibit much more severe phenotypes than those with other types. Hotspot mutations or regions exist in patients with all types of PH and show differences among ethnicities. Genotype-phenotype correlations are observed in PH1 and PH3.

摘要

原发性高草酸尿症(PH)是一种罕见的单基因疾病,其特征为复发性肾结石、肾钙质沉着症和肾功能损害。为研究基因型和表型特征,我们评估了2016年5月至2022年4月期间确诊的42例中国儿科PH患者的临床资料。我们发现,PH3型患者的发病年龄比PH1型和PH2型患者更早(分别为1岁、5岁和8岁,<0.001)。PH1和PH2患者的尿枸橼酸盐显著低于PH3患者(分别为91.81和85.56对比163.9 g/mg,=0.044)。PH1患者的随机尿草酸水平略高于PH2和PH3患者(分别为457.9对比182.38和309.14 g/mg,=0.189)。在整个PH队列(= -0.360,=0.04)和PH3队列(= -0.674,=0.003)中,观察到尿钙/肌酐比值与草酸/肌酐比值之间存在显著负相关。PH致病基因显示热点突变或区域,包括 中的c.815_816insGA和c.33dup、 中的864_865del以及 中的外显子6跳跃和c.769T>G。在PH1队列中,杂合子c.33dup患者的估计肾小球滤过率(eGFR)最低。在PH3队列中,杂合子外显子6跳跃的患者eGFR最低,且肾脏生存优势显著降低。总之,PH1患者的表型比其他类型患者严重得多。所有类型的PH患者均存在热点突变或区域,且在不同种族之间存在差异。在PH1和PH3中观察到基因型-表型相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf3/11918535/9ef781268983/HUMU2023-4875680.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf3/11918535/e1ee369e0041/HUMU2023-4875680.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf3/11918535/b2ea60797bef/HUMU2023-4875680.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf3/11918535/80a12308376a/HUMU2023-4875680.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf3/11918535/9ef781268983/HUMU2023-4875680.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf3/11918535/e1ee369e0041/HUMU2023-4875680.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf3/11918535/b2ea60797bef/HUMU2023-4875680.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf3/11918535/80a12308376a/HUMU2023-4875680.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf3/11918535/9ef781268983/HUMU2023-4875680.004.jpg

相似文献

1
Genotype and Phenotype Characteristics of Chinese Pediatric Patients with Primary Hyperoxaluria.中国原发性高草酸尿症儿科患者的基因型和表型特征
Hum Mutat. 2023 Sep 14;2023:4875680. doi: 10.1155/2023/4875680. eCollection 2023.
2
Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.在中国儿童中发现的 3 型原发性高草酸尿症中 9 种新型 HOGA1 基因突变及不同的临床和生化特征。
Pediatr Nephrol. 2019 Oct;34(10):1785-1790. doi: 10.1007/s00467-019-04279-7. Epub 2019 May 23.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Primary Hyperoxaluria Type 11型原发性高草酸尿症
5
Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2.原发性高草酸尿症 3 型与 1 型和 2 型的临床特征比较。
Nephrol Dial Transplant. 2022 Apr 25;37(5):869-875. doi: 10.1093/ndt/gfab027.
6
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
7
Identification of 8 novel gene variants in primary hyperoxaluria in 21 Chinese children with urinary stones.鉴定 21 例尿路结石的原发性高草酸尿症患儿中的 8 种新基因变异。
World J Urol. 2019 Aug;37(8):1713-1721. doi: 10.1007/s00345-018-2563-5. Epub 2018 Nov 28.
8
Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study.伴 X 连锁低磷血症的儿童和成人的肾钙质沉着症和肾功能:一项大型纵向研究的基线结果。
J Bone Miner Res. 2024 Sep 26;39(10):1493-1502. doi: 10.1093/jbmr/zjae127.
9
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.人乳头瘤病毒基因分型检测在日本女性自行采集的尿液和阴道样本癌症筛查中的效用
Gynecol Obstet Invest. 2025;90(2):143-152. doi: 10.1159/000541641. Epub 2024 Oct 7.
10
A Putative Mutation Hotspot of the AGXT Gene Associated with Primary Hyperoxaluria Type 1 in the Chinese Population.中国人群中与1型原发性高草酸尿症相关的AGXT基因的一个假定突变热点
Tohoku J Exp Med. 2018 Dec;246(4):233-241. doi: 10.1620/tjem.246.233.

本文引用的文献

1
Genetic assessment in primary hyperoxaluria: why it matters.原发性高草酸尿症的遗传评估:为何重要。
Pediatr Nephrol. 2023 Mar;38(3):625-634. doi: 10.1007/s00467-022-05613-2. Epub 2022 Jun 13.
2
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1.鲁马西拉治疗1型原发性高草酸尿症患者长期疗效和安全性的随机临床试验
Kidney Int Rep. 2021 Dec 11;7(3):494-506. doi: 10.1016/j.ekir.2021.12.001. eCollection 2022 Mar.
3
Comparison of Renal Stones and Nephrocalcinosis in Children: Findings From Two Tertiary Centers in Saudi Arabia.
沙特阿拉伯两个三级医疗中心儿童肾结石与肾钙质沉着症的比较研究结果
Front Pediatr. 2022 Jan 17;9:736308. doi: 10.3389/fped.2021.736308. eCollection 2021.
4
Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease.综合基因分析揭示单基因尿路结石病的复杂性。
Kidney Int Rep. 2021 Sep 8;6(11):2862-2884. doi: 10.1016/j.ekir.2021.08.033. eCollection 2021 Nov.
5
Primary Hyperoxaluria Type 3 Can Also Result in Kidney Failure: A Case Report.原发性高草酸尿症 3 型也可导致肾衰竭:病例报告。
Am J Kidney Dis. 2022 Jan;79(1):125-128. doi: 10.1053/j.ajkd.2021.05.016. Epub 2021 Jul 7.
6
Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1.对疑似 1 型原发性高草酸尿症的叙利亚患者的 AGXT 基因进行分子分析。
BMC Med Genomics. 2021 Jun 3;14(1):146. doi: 10.1186/s12920-021-00996-x.
7
Possible ethnic associations in primary hyperoxaluria type-III-associated HOGA1 sequence variants.可能与原发性高草酸尿症 III 型相关的 HOGA1 序列变异存在种族相关性。
Mol Biol Rep. 2021 Apr;48(4):3841-3844. doi: 10.1007/s11033-021-06380-3. Epub 2021 May 4.
8
A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3.原发性高草酸尿症 3 型患者的大型队列的欧洲高草酸尿症联合会(OxalEurope)登记处报告。
Kidney Int. 2021 Sep;100(3):621-635. doi: 10.1016/j.kint.2021.03.031. Epub 2021 Apr 16.
9
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.卢马昔兰,用于 1 型原发性高草酸尿症的 RNAi 疗法。
N Engl J Med. 2021 Apr 1;384(13):1216-1226. doi: 10.1056/NEJMoa2021712.
10
Clinical analysis of 13 children with primary hyperoxaluria type 1.1 型原发性高草酸尿症 13 例临床分析。
Urolithiasis. 2021 Oct;49(5):425-431. doi: 10.1007/s00240-021-01249-3. Epub 2021 Mar 15.